-
1
-
-
74549128529
-
Epidemiology of hepatitis B and C viruses: A global overview
-
vii
-
Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis: 2010; 14 1 1 21, vii
-
(2010)
Clin Liver Dis
, vol.14
, Issue.1
, pp. 1-21
-
-
Te, H.S.1
Jensen, D.M.2
-
2
-
-
20244373332
-
Hepatitis B and HIV: Prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort
-
Konopnicki D, Mocroft A, de Wit S., et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS: 2005; 19 2117 2125
-
(2005)
AIDS
, vol.19
, pp. 2117-2125
-
-
Konopnicki, D.1
Mocroft, A.2
De Wit, S.3
-
3
-
-
75749135627
-
Epidemiology of hepatitis B virus infection in a US cohort of HIV-infected individuals during the past 20 years
-
Infectious Disease Clinical Research Program HIV Working Group
-
Chun HM, Fieberg AM, Hullsiek KH., et al. Infectious Disease Clinical Research Program HIV Working Group Epidemiology of hepatitis B virus infection in a US cohort of HIV-infected individuals during the past 20 years. Clin Infect Dis: 2010; 50 3 426 436
-
(2010)
Clin Infect Dis
, vol.50
, Issue.3
, pp. 426-436
-
-
Chun, H.M.1
Fieberg, A.M.2
Hullsiek, K.H.3
-
4
-
-
0042442264
-
Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects
-
Kellerman S, Hanson D, McNaghten A, Fleming P. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. J Infect Dis: 2003; 188 571 577
-
(2003)
J Infect Dis
, vol.188
, pp. 571-577
-
-
Kellerman, S.1
Hanson, D.2
McNaghten, A.3
Fleming, P.4
-
5
-
-
77950329915
-
Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe
-
EuroSIDA.
-
Soriano V, Mocroft A, Peters L., et al. EuroSIDA. Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe. J Antimicrob Chemother: 2010; 65 3 548 555
-
(2010)
J Antimicrob Chemother
, vol.65
, Issue.3
, pp. 548-555
-
-
Soriano, V.1
Mocroft, A.2
Peters, L.3
-
6
-
-
66149175804
-
The natural history of chronic hepatitis B virus infection
-
McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology: 2009; 49 5, Suppl S45 S55
-
(2009)
Hepatology
, vol.49
, Issue.5 SUPPL.
-
-
McMahon, B.J.1
-
7
-
-
33644858331
-
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
-
Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer-In HBV (the REVEAL-HBV) Study Group
-
Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ.; Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer-In HBV (the REVEAL-HBV) Study Group Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology: 2006; 130 3 678 686
-
(2006)
Gastroenterology
, vol.130
, Issue.3
, pp. 678-686
-
-
Iloeje, U.H.1
Yang, H.I.2
Su, J.3
Jen, C.L.4
You, S.L.5
Chen, C.J.6
-
8
-
-
29944436855
-
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
-
REVEAL-HBV Study Group
-
Chen CJ, Yang HI, Su J., et al. REVEAL-HBV Study Group Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA: 2006; 295 1 65 73
-
(2006)
JAMA
, vol.295
, Issue.1
, pp. 65-73
-
-
Chen, C.J.1
Yang, H.I.2
Su, J.3
-
9
-
-
30144442223
-
Natural history of chronic hepatitis B in co-infected patients
-
Puoti M, Torti C, Bruno R, Filice G, Carosi G. Natural history of chronic hepatitis B in co-infected patients. J Hepatol: 2006; 44 1, Suppl S65 S70
-
(2006)
J Hepatol
, vol.44
, Issue.1 SUPPL.
-
-
Puoti, M.1
Torti, C.2
Bruno, R.3
Filice, G.4
Carosi, G.5
-
10
-
-
79954708052
-
Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006
-
Walter SR, Thein HH, Amin J., et al. Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006. J Hepatol: 2011; 54 5 879 886
-
(2011)
J Hepatol
, vol.54
, Issue.5
, pp. 879-886
-
-
Walter, S.R.1
Thein, H.H.2
Amin, J.3
-
11
-
-
78650307553
-
Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues
-
Martín-Carbonero L, Teixeira T, Poveda E., et al. Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues. AIDS: 2011; 25 1 73 79
-
(2011)
AIDS
, vol.25
, Issue.1
, pp. 73-79
-
-
Martín-Carbonero, L.1
Teixeira, T.2
Poveda, E.3
-
12
-
-
55249118634
-
Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma
-
Swiss HIV Cohort.
-
Clifford GM, Rickenbach M, Polesel J., et al. Swiss HIV Cohort. Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma. AIDS: 2008; 22 16 2135 2141
-
(2008)
AIDS
, vol.22
, Issue.16
, pp. 2135-2141
-
-
Clifford, G.M.1
Rickenbach, M.2
Polesel, J.3
-
13
-
-
66149187114
-
Hepatitis B and human immunodeficiency virus coinfection
-
Thio CL. Hepatitis B and human immunodeficiency virus coinfection. Hepatology: 2009; 49 5, Suppl S138 S145
-
(2009)
Hepatology
, vol.49
, Issue.5 SUPPL.
-
-
Thio, C.L.1
-
14
-
-
85062055676
-
Liver-related deaths in persons with the human immunodeficiency virus: The D:A:D study
-
Weber R, Sabin C, Friis-Moller N., et al. Liver-related deaths in persons with the human immunodeficiency virus: the D:A:D study. Arch Intern Med: 2006; 166 1632 1641
-
(2006)
Arch Intern Med
, vol.166
, pp. 1632-1641
-
-
Weber, R.1
Sabin, C.2
Friis-Moller, N.3
-
15
-
-
66949175946
-
Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: A cohort study and meta-analysis
-
Nikolopoulos GK, Paraskevis D, Hatzitheodorou E., et al. Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis. Clin Infect Dis: 2009; 48 12 1763 1771
-
(2009)
Clin Infect Dis
, vol.48
, Issue.12
, pp. 1763-1771
-
-
Nikolopoulos, G.K.1
Paraskevis, D.2
Hatzitheodorou, E.3
-
16
-
-
0037079352
-
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
-
Multicenter AIDS Cohort Study.
-
Thio CL, Seaberg EC, Skolasky R Jr., et al. Multicenter AIDS Cohort Study. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet: 2002; 360 9349 1921 1926
-
(2002)
Lancet
, vol.360
, Issue.9349
, pp. 1921-1926
-
-
Thio, C.L.1
Seaberg, E.C.2
Skolasky Jr., R.3
-
17
-
-
70349902495
-
Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria
-
Idoko J, Meloni S, Muazu M., et al. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria. Clin Infect Dis: 2009; 49 1268 1273
-
(2009)
Clin Infect Dis
, vol.49
, pp. 1268-1273
-
-
Idoko, J.1
Meloni, S.2
Muazu, M.3
-
18
-
-
77949566352
-
Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruption
-
SMART INSIGHT study group
-
Dore GJ, Soriano V, Rockstroh J., et al. SMART INSIGHT study group Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruption. AIDS: 2010; 24 6 857 865
-
(2010)
AIDS
, vol.24
, Issue.6
, pp. 857-865
-
-
Dore, G.J.1
Soriano, V.2
Rockstroh, J.3
-
19
-
-
70249142882
-
Hepatitis B and long-term HIV outcomes in coinfected HAART recipients
-
Hoffmann CJ, Seaberg EC, Young S., et al. Hepatitis B and long-term HIV outcomes in coinfected HAART recipients. AIDS: 2009; 23 14 1881 1889
-
(2009)
AIDS
, vol.23
, Issue.14
, pp. 1881-1889
-
-
Hoffmann, C.J.1
Seaberg, E.C.2
Young, S.3
-
20
-
-
0034606721
-
Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection
-
Sulkowski M, Thomas D, Chaisson R., et al. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA: 2000; 283 74 80
-
(2000)
JAMA
, vol.283
, pp. 74-80
-
-
Sulkowski, M.1
Thomas, D.2
Chaisson, R.3
-
21
-
-
0036153954
-
Hepatotoxicity development during antiretroviral therapy containing protease inhibitors in patients with HIV: The role of hepatitis B and C virus infection
-
LIVERHAART Group
-
Aceti A, Pasquazzi C, Zechini B, De Bac C.; LIVERHAART Group Hepatotoxicity development during antiretroviral therapy containing protease inhibitors in patients with HIV: the role of hepatitis B and C virus infection. J Acquir Immune Defic Syndr: 2002; 29 1 41 48
-
(2002)
J Acquir Immune Defic Syndr
, vol.29
, Issue.1
, pp. 41-48
-
-
Aceti, A.1
Pasquazzi, C.2
Zechini, B.3
De Bac, C.4
-
22
-
-
37349034179
-
Antiretroviral drugs and liver injury
-
Soriano V, Puoti M, Garcia-Gascó P., et al. Antiretroviral drugs and liver injury. AIDS: 2008; 22 1 1 13
-
(2008)
AIDS
, vol.22
, Issue.1
, pp. 1-13
-
-
Soriano, V.1
Puoti, M.2
Garcia-Gascó, P.3
-
23
-
-
7744230430
-
Survival in patients with HIV infection and viral hepatitis B or C: A cohort study
-
Bonacini M, Louie S, Bzowej N, Wohl AR. Survival in patients with HIV infection and viral hepatitis B or C: a cohort study. AIDS: 2004; 18 15 2039 2045
-
(2004)
AIDS
, vol.18
, Issue.15
, pp. 2039-2045
-
-
Bonacini, M.1
Louie, S.2
Bzowej, N.3
Wohl, A.R.4
-
25
-
-
84858138940
-
-
European AIDS Clinical Society Version 6.0, October Available at Accessed December 2, 2011
-
European AIDS Clinical Society. European AIDS Clinical Society Guidelines. Version 6.0, October, 2011. Available at: http://www. europeanaidsclinicalsociety.org. Accessed December 2, 2011
-
(2011)
European AIDS Clinical Society Guidelines
-
-
-
26
-
-
49849099939
-
Care of HIV patients with chronic hepatitis B: Updated recommendations from the HIV-Hepatitis B Virus International Panel
-
Soriano V, Puoti M, Peters M., et al. Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel. AIDS: 2008; 22 12 1399 1410
-
(2008)
AIDS
, vol.22
, Issue.12
, pp. 1399-1410
-
-
Soriano, V.1
Puoti, M.2
Peters, M.3
-
27
-
-
78649711070
-
Long-term therapy with tenofovir is effective for patients coinfected with human immunodeficiency virus and hepatitis B virus
-
Vries-Sluijs T, Reijnders J, Hansen B., et al. Long-term therapy with tenofovir is effective for patients coinfected with human immunodeficiency virus and hepatitis B virus. Gastroenterology: 2010; 139 1934 1941
-
(2010)
Gastroenterology
, vol.139
, pp. 1934-1941
-
-
Vries-Sluijs, T.1
Reijnders, J.2
Hansen, B.3
-
28
-
-
67649467275
-
Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: Another benefit of HAART in those with preserved CD4 count
-
Landrum ML, Huppler Hullsiek K, Ganesan A., et al. Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: another benefit of HAART in those with preserved CD4 count. Vaccine: 2009; 27 34 4731 4738
-
(2009)
Vaccine
, vol.27
, Issue.34
, pp. 4731-4738
-
-
Landrum, M.L.1
Huppler Hullsiek, K.2
Ganesan, A.3
-
29
-
-
57049153416
-
Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients
-
Cruciani M, Mengoli C, Serpelloni G., et al. Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients. Vaccine: 2009; 27 1 17 22
-
(2009)
Vaccine
, vol.27
, Issue.1
, pp. 17-22
-
-
Cruciani, M.1
Mengoli, C.2
Serpelloni, G.3
-
30
-
-
27644490225
-
Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus
-
Laurence JC. Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus. Am J Med: 2005; 118 Suppl 10A 75S 83S
-
(2005)
Am J Med
, vol.118
, Issue.SUPPL. 10A
-
-
Laurence, J.C.1
-
31
-
-
57149091722
-
A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update
-
quiz 1286
-
Keeffe EB, Dieterich DT, Han SH., et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol: 2008; 6 12 1315 1341, quiz 1286
-
(2008)
Clin Gastroenterol Hepatol
, vol.6
, Issue.12
, pp. 1315-1341
-
-
Keeffe, E.B.1
Dieterich, D.T.2
Han, S.H.3
-
32
-
-
58149296156
-
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
-
European Association for the Study of the Liver.
-
European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol: 2009; 50 2 227 242
-
(2009)
J Hepatol
, vol.50
, Issue.2
, pp. 227-242
-
-
-
33
-
-
33645017628
-
Confronting chronic hepatitis B virus infection in HIV: New diagnostic tools and more weapons
-
Soriano V, Sheldon J, Ramos B, Núñez M. Confronting chronic hepatitis B virus infection in HIV: new diagnostic tools and more weapons. AIDS: 2006; 20 3 451 453
-
(2006)
AIDS
, vol.20
, Issue.3
, pp. 451-453
-
-
Soriano, V.1
Sheldon, J.2
Ramos, B.3
Núñez, M.4
-
34
-
-
79958038529
-
Peginterferon alpha-based therapy for chronic hepatitis B focusing on HBsAg clearance or seroconversion: A meta-analysis of controlled clinical trials
-
Li WC, Wang MR, Kong LB, Ren WG, Zhang YG, Nan YM. Peginterferon alpha-based therapy for chronic hepatitis B focusing on HBsAg clearance or seroconversion: a meta-analysis of controlled clinical trials. BMC Infect Dis: 2011; 11 165
-
(2011)
BMC Infect Dis
, vol.11
, pp. 165
-
-
Li, W.C.1
Wang, M.R.2
Kong, L.B.3
Ren, W.G.4
Zhang, Y.G.5
Nan, Y.M.6
-
35
-
-
0036892339
-
Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B
-
Di Martino V, Thevenot T, Colin JF., et al. Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B. Gastroenterology: 2002; 123 6 1812 1822
-
(2002)
Gastroenterology
, vol.123
, Issue.6
, pp. 1812-1822
-
-
Di Martino, V.1
Thevenot, T.2
Colin, J.F.3
-
36
-
-
33644818518
-
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
-
Chang TT, Gish RG, De Man R., et al. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med: 2006; 354 10 1001 1010
-
(2006)
N Engl J Med
, vol.354
, Issue.10
, pp. 1001-1010
-
-
Chang, T.T.1
Gish, R.G.2
De Man, R.3
-
37
-
-
33644822860
-
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
-
BEHoLD AI463027 Study Group
-
Lai CL, Shouval D, Lok AS., et al. BEHoLD AI463027 Study Group Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N Engl J Med: 2006; 354 10 1011 1020
-
(2006)
N Engl J Med
, vol.354
, Issue.10
, pp. 1011-1020
-
-
Lai, C.L.1
Shouval, D.2
Lok, A.S.3
-
38
-
-
77953430954
-
Genotypic determinants and phenotypic properties of antiviral-resistant HBV variants: Insight from entecavir resistance studies
-
Tenney DJ. Genotypic determinants and phenotypic properties of antiviral-resistant HBV variants: insight from entecavir resistance studies. Antivir Ther: 2010; 15 3 Pt B 529 535
-
(2010)
Antivir Ther
, vol.15
, Issue.3 PART B
, pp. 529-535
-
-
Tenney, D.J.1
-
39
-
-
34250722018
-
The HBV drug entecavireffects on HIV-1 replication and resistance
-
McMahon MA, Jilek BL, Brennan TP., et al. The HBV drug entecavireffects on HIV-1 replication and resistance. N Engl J Med: 2007; 356 25 2614 2621
-
(2007)
N Engl J Med
, vol.356
, Issue.25
, pp. 2614-2621
-
-
McMahon, M.A.1
Jilek, B.L.2
Brennan, T.P.3
-
40
-
-
79954576654
-
New 2011 updated DHHS antiretroviral treatment guidelines and chronic hepatitis B
-
Soriano V, Vispo E, Barreiro P. New 2011 updated DHHS antiretroviral treatment guidelines and chronic hepatitis B. AIDS: 2011; 25 7 1013 1014
-
(2011)
AIDS
, vol.25
, Issue.7
, pp. 1013-1014
-
-
Soriano, V.1
Vispo, E.2
Barreiro, P.3
-
41
-
-
79955609622
-
Managing hepatitis B/HIV co-infected: Adding entecavir to truv
-
ada (tenofovir disoproxil/emtricitabine) experienced patients
-
Ratcliffe L, Beadsworth M, Pennell A, Fillips M, Vilar FJ. Managing hepatitis B/HIV co-infected: adding entecavir to truv. ada (tenofovir disoproxil/emtricitabine) experienced patients. AIDS: 2011; 25 8 1051 1056
-
(2011)
AIDS
, vol.25
, Issue.8
, pp. 1051-1056
-
-
Ratcliffe, L.1
Beadsworth, M.2
Pennell, A.3
Fillips, M.4
Vilar, F.J.5
-
42
-
-
34248188710
-
Telbivudine: A new option for the treatment of chronic hepatitis B
-
Ruiz-Sancho A, Sheldon J, Soriano V. Telbivudine: a new option for the treatment of chronic hepatitis B. Expert Opin Biol Ther: 2007; 7 5 751 761
-
(2007)
Expert Opin Biol Ther
, vol.7
, Issue.5
, pp. 751-761
-
-
Ruiz-Sancho, A.1
Sheldon, J.2
Soriano, V.3
-
43
-
-
62349140803
-
Telbivudine has activity against HIV-1
-
Low E, Cox A, Atkins M, Nelson M. Telbivudine has activity against HIV-1. AIDS: 2009; 23 4 546 547
-
(2009)
AIDS
, vol.23
, Issue.4
, pp. 546-547
-
-
Low, E.1
Cox, A.2
Atkins, M.3
Nelson, M.4
-
44
-
-
77952647304
-
Telbivudine exhibits no inhibitory activity against HIV-1 clinical isolates in vitro
-
Lin K, Karwowska S, Lam E, Limoli K, Evans TG, Avila C. Telbivudine exhibits no inhibitory activity against HIV-1 clinical isolates in vitro. Antimicrob Agents Chemother: 2010; 54 6 2670 2673
-
(2010)
Antimicrob Agents Chemother
, vol.54
, Issue.6
, pp. 2670-2673
-
-
Lin, K.1
Karwowska, S.2
Lam, E.3
Limoli, K.4
Evans, T.G.5
Avila, C.6
-
45
-
-
33745189870
-
Mutations affecting the replication capacity of the hepatitis B virus
-
Sheldon J, Rodès B, Zoulim F, Bartholomeusz A, Soriano V. Mutations affecting the replication capacity of the hepatitis B virus. J Viral Hepat: 2006; 13 7 427 434
-
(2006)
J Viral Hepat
, vol.13
, Issue.7
, pp. 427-434
-
-
Sheldon, J.1
Rodès, B.2
Zoulim, F.3
Bartholomeusz, A.4
Soriano, V.5
-
47
-
-
34547792213
-
A novel mutation pattern emerging during lamivudine treatment shows cross-resistance to adefovir dipivoxil treatment
-
Karatayli E, Karayalçin S, Karaaslan H., et al. A novel mutation pattern emerging during lamivudine treatment shows cross-resistance to adefovir dipivoxil treatment. Antivir Ther: 2007; 12 5 761 768
-
(2007)
Antivir Ther
, vol.12
, Issue.5
, pp. 761-768
-
-
Karatayli, E.1
Karayalçin, S.2
Karaaslan, H.3
-
48
-
-
0032760120
-
Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients
-
Benhamou Y, Bochet M, Thibault V., et al. Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients. Hepatology: 1999; 30 1302 1306
-
(1999)
Hepatology
, vol.30
, pp. 1302-1306
-
-
Benhamou, Y.1
Bochet, M.2
Thibault, V.3
-
49
-
-
55849138005
-
Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program
-
Hoffmann CJ, Charalambous S, Martin DJ., et al. Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program. Clin Infect Dis: 2008; 47 11 1479 1485
-
(2008)
Clin Infect Dis
, vol.47
, Issue.11
, pp. 1479-1485
-
-
Hoffmann, C.J.1
Charalambous, S.2
Martin, D.J.3
-
50
-
-
55849120853
-
Risks and benefits of using antiretroviral therapy in HIV-infected patients with chronic hepatitis B in developing regions
-
Soriano V, Rivas P, Nuñez M. Risks and benefits of using antiretroviral therapy in HIV-infected patients with chronic hepatitis B in developing regions. Clin Infect Dis: 2008; 47 11 1486 1489
-
(2008)
Clin Infect Dis
, vol.47
, Issue.11
, pp. 1486-1489
-
-
Soriano, V.1
Rivas, P.2
Nuñez, M.3
-
51
-
-
33646706854
-
Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy
-
Matthews GV, Bartholomeusz A, Locarnini S., et al. Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy. AIDS: 2006; 20 6 863 870
-
(2006)
AIDS
, vol.20
, Issue.6
, pp. 863-870
-
-
Matthews, G.V.1
Bartholomeusz, A.2
Locarnini, S.3
-
52
-
-
4143053549
-
Severe hepatitis and prolonged hepatitis B virus-specific CD8 T-cell response after selection of hepatitis B virus YMDD variant in an HIV/hepatitis B virus-co-infected patient
-
Gouskos T, Wightman F, Chang J., et al. Severe hepatitis and prolonged hepatitis B virus-specific CD8 T-cell response after selection of hepatitis B virus YMDD variant in an HIV/hepatitis B virus-co-infected patient. AIDS: 2004; 18 12 1734 1737
-
(2004)
AIDS
, vol.18
, Issue.12
, pp. 1734-1737
-
-
Gouskos, T.1
Wightman, F.2
Chang, J.3
-
53
-
-
33847028842
-
Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance
-
Hsu CW, Yeh CT, Chang ML, Liaw YF. Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance. Gastroenterology: 2007; 132 2 543 550
-
(2007)
Gastroenterology
, vol.132
, Issue.2
, pp. 543-550
-
-
Hsu, C.W.1
Yeh, C.T.2
Chang, M.L.3
Liaw, Y.F.4
-
54
-
-
41149084629
-
Hepatitis B virus escape mutants induced by antiviral therapy
-
Sheldon J, Soriano V. Hepatitis B virus escape mutants induced by antiviral therapy. J Antimicrob Chemother: 2008; 61 4 766 768
-
(2008)
J Antimicrob Chemother
, vol.61
, Issue.4
, pp. 766-768
-
-
Sheldon, J.1
Soriano, V.2
-
55
-
-
77950312767
-
New paradigms for treating hepatitis B in HIV/hepatitis B virus co-infected patients
-
Martín-Carbonero L, Soriano V. New paradigms for treating hepatitis B in HIV/hepatitis B virus co-infected patients. J Antimicrob Chemother: 2010; 65 3 379 382
-
(2010)
J Antimicrob Chemother
, vol.65
, Issue.3
, pp. 379-382
-
-
Martín-Carbonero, L.1
Soriano, V.2
-
56
-
-
25444459427
-
Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir
-
Sheldon J, Camino N, Rodés B., et al. Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir. Antivir Ther: 2005; 10 6 727 734
-
(2005)
Antivir Ther
, vol.10
, Issue.6
, pp. 727-734
-
-
Sheldon, J.1
Camino, N.2
Rodés, B.3
-
57
-
-
0037016387
-
Primary infection with a lamivudine-resistant hepatitis B virus
-
Thibault V, Aubron-Olivier C, Agut H, Katlama C. Primary infection with a lamivudine-resistant hepatitis B virus. AIDS: 2002; 16 1 131 133
-
(2002)
AIDS
, vol.16
, Issue.1
, pp. 131-133
-
-
Thibault, V.1
Aubron-Olivier, C.2
Agut, H.3
Katlama, C.4
-
58
-
-
79959482415
-
HBV primary drug resistance in newly diagnosed HIV-HBV-coinfected individuals in Spain
-
CoRIS Study Group
-
Tuma P, Pineda JA, Labarga P., et al. CoRIS Study Group HBV primary drug resistance in newly diagnosed HIV-HBV-coinfected individuals in Spain. Antivir Ther: 2011; 16 4 585 589
-
(2011)
Antivir Ther
, vol.16
, Issue.4
, pp. 585-589
-
-
Tuma, P.1
Pineda, J.A.2
Labarga, P.3
-
59
-
-
77954658782
-
Acute hepatitis B infection associated with drug-resistant hepatitis B virus
-
Xu Z, Liu Y, Xu T., et al. Acute hepatitis B infection associated with drug-resistant hepatitis B virus. J Clin Virol: 2010; 48 4 270 274
-
(2010)
J Clin Virol
, vol.48
, Issue.4
, pp. 270-274
-
-
Xu, Z.1
Liu, Y.2
Xu, T.3
-
60
-
-
73149115449
-
Lamivudine-resistant mutation among treatment-naïve hepatitis B patients is common and may be associated with treatment failure
-
Abstract presented at October 31-November 4 San Francisco, CA; Abstract 888
-
Fung S, Mazulli T, El-Kashab M., et al. Lamivudine-resistant mutation among treatment-naïve hepatitis B patients is common and may be associated with treatment failure. Abstract presented at: Annual Meeting of the American Association for the Study of Liver Diseases; October 31-November 4, 2008; San Francisco, CA; Abstract 888
-
(2008)
Annual Meeting of the American Association for the Study of Liver Diseases
-
-
Fung, S.1
Mazulli, T.2
El-Kashab, M.3
|